FDA Greenlights First Drug for Agitation Related to Alzheimer Disease. Harris E. JAMA 2023 May 24. doi: 10.1001/jama.2023.9153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harris E. FDA Greenlights First Drug for Agitation Related to Alzheimer Disease. JAMA 2023 May 24. doi: 10.1001/jama.2023.9153.
PMID: 37223961